Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

8 Best “Sin Stocks” to Buy for Recession Protection

Page 1 of 2

In this article, we will take a look at the 8 Best “Sin Stocks” to Buy for Recession Protection.

US equity market futures fell early on June 22 as Wall Street reviewed the latest developments in US-Iran peace talks and awaited vital inflation data closely monitored by the Fed. The market slumped following comments from mediators Qatar and Pakistan that US and Iranian officials had reached terms on a plan to establish a final peace agreement within 60 days.

On June 18, Tom Lee, head of research at Fundstrat Global Advisors, told CNBC that although a number of key factors could affect markets, “conditions are still favorable for stocks.” However, the firm cautioned that “later this year, there is going to be an abrupt change of market conditions” that might resemble a bear market.

However, Michele Morganti, senior equity strategist at Generali Investments, said the overall market environment remained positive. As stated by the analyst:

“The AI tide is lifting all manufacturing boats, the US economy is holding up well, and EM economies have proved more resilient than in past crises.”

The spotlight is now anticipated to move to PCE inflation figures, which are the Federal Reserve’s favored measure of core inflation. Markets are currently expecting a 25-basis-point rate increase from the Fed in September, as officials signal higher borrowing costs to offset inflation pressures.

With that in mind, let’s take a look at the best sin stocks to buy right now for recession protection.

Our Methodology

For this list, we used the AdvisorShares Vice ETF, which invests in products and services that people enjoy regardless of the economic situation. VICE seeks long-term growth from select global companies involved in “vice” industries such as alcohol, tobacco, and gaming. To further narrow the list, we used hedge fund sentiment and positive analyst commentary. Our final list is ranked in ascending order based on the number of hedge funds holding bullish positions in each stock.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).

8. Alto Ingredients, Inc. (NASDAQ:ALTO)

Number of Hedge Fund Holders: 21

Alto Ingredients, Inc. (NASDAQ:ALTO) ranks among the best sin stocks to buy for recession protection. On May 7, H.C. Wainwright analyst Amit Dayal boosted Alto Ingredients, Inc. (NASDAQ:ALTO) price target to $10 from $5.50, maintaining a Buy rating on the company’s stock. The firm claims that improvements in macroeconomic conditions for the renewable fuels sector in recent quarters have led to “an environment for steady operational profitability for the business that was lacking previously.”

Moreover, a day earlier, the company posted Q1 2026 results with net income of $4.0 million, compared with a net loss of $12.0 million in the same quarter of the previous year. The recovery was most apparent in adjusted EBITDA, which hit a positive $4.7 million from negative $4.4 million in the first quarter of 2025.

With a $11.3 million increase in gross profit, the Pekin Campus led the recovery, going from a $3.1 million deficit to an $8.2 million gain. The site, consisting of dry mill, wet mill, and yeast plant activities, profited from a better product mix and the incorporation of 45Z tax credit benefits.

​Alto Ingredients, Inc. (NASDAQ:ALTO) produces and distributes specialty alcohols, renewable fuels like ethanol, and essential ingredients derived mainly from corn.

7. Ambev S.A. (NYSE:ABEV)

Number of Hedge Fund Holders: 21

Ambev S.A. (NYSE:ABEV) ranks among the best sin stocks to buy for recession protection. On May 6, Bernstein SocGen Group boosted its price target for Ambev S.A. (NYSE:ABEV) to $3.73 from $3.42, while keeping a Market Perform rating on the company’s shares. The firm reported that the Brazilian beer market continued to fall in the mid-single range, with the company indicating a 3% drop in a sell-side follow-up discussion as weather conditions remained challenging.

According to Bernstein, Ambev S.A. (NYSE:ABEV) has achieved solid volume success, despite the fact that the whole market has yet to return to growth. According to the firm, comparisons will become easier beginning in the second quarter of 2026, with World Cup tailwinds forecast.

Additionally, management described Ambev’s Q1 2026 results, which were released a day earlier, as a “solid start of the year.” The company’s revenue of $4.33 billion was in line with market expectations, while its earnings per share of $0.0463 exceeded analyst estimates of $0.0446 by 3.81%.

The premium segment, which includes brands like Stella Artois, Corona, and Spaten, rose by over 20% during the quarter. Meanwhile, the balanced options portfolio, which includes low-calorie and alcohol-free options, rose by more than 70%.

Ambev S.A. (NYSE:ABEV) produces, distributes, and sells beverages. It manufactures beer, carbonated soft drinks, and various non-alcoholic and non-carbonated products. It functions across the following geographic areas: Brazil, Central America and the Caribbean (CAC), and Canada.

Page 1 of 2

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.